Nasdaq

Wait For A Dip To Buy DexCom Stock

DexCom (NASDAQ:DXCM) stock experienced a significant 16% surge on Friday following its Q1 earnings release and a share buyback announcement. The company’s first-quarter sales reached $1.04 billion, ...
Yahoo Finance

How The DexCom (DXCM) Investment Story Is Shifting With New Guidance And Valuation Resets

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Forbes

Will DexCom Stock Rebound To Its 2021 Highs Of $160?

DexCom stock (NASDAQ: DXCM) currently trades at $73 per share, around 55% below the highs of $163 seen in November 2021. In comparison, Insulet stock (NASDAQ: PODD) saw its stock decline 39% over the ...
The Motley Fool

If You'd Invested $1,000 in DexCom 10 Years Ago, Here's How Much You'd Have Today

DexCom develops and markets continuous glucose monitoring (CGM) systems, a type of device that continuously tracks blood sugar levels. The technology isn't exactly new anymore, and it has enjoyed ...
Nasdaq

DexCom Announces 4-for-1 Stock Split. Here's What Investors Need to Know.

DexCom (NASDAQ: DXCM) has revolutionized the lives of people suffering from diabetes. The company introduced the first real-time continuous glucose monitoring (CGM) system back in 2006, raising the ...
The Motley Fool

Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?

DexCom's entire business is built around diabetes. Every penny of the company's first-quarter revenue of $921 million came from its continuous glucose monitoring (CGM) systems. These CGM devices are ...
Business Wire

Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests

EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the publication of a ...
Business Wire

DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, will showcase for the first time its new global ...
Morningstar

Dexcom Comes Under Greater Competitive Pressure From Abbott, but There’s Room for Both To Grow

Despite rival Abbott’s recent U.S. regulatory approval for integration of its Libre 2 and Libre 3 continuous glucose monitors, or CGM, with insulin pumps, we don’t anticipate changing our fair value ...
Forbes

Will DexCom Stock Recover To Its Pre-Inflation Shock Highs Of $160?

Ed Gamble and Roxy Horner, who live with Type 1 diabetes, at the Dexcom's "No Pricks Parlour" vintage ice cream truck, handing out free ice cream on London's South Bank to celebrate Diabetes Awareness ...